Biomarker-enhanced Artificial Intelligence Based Pediatric Sepsis Screening Tool

Not yet recruitingOBSERVATIONAL
Enrollment

12,961

Participants

Timeline

Start Date

April 1, 2026

Primary Completion Date

March 31, 2029

Study Completion Date

March 31, 2029

Conditions
Sepsis
Interventions
DIAGNOSTIC_TEST

Pediatric sepsis screening tool (either algorithmic or manual)

All participating institutions employ either an algorithmic, manual, or combined algorithmic/manual pediatric sepsis screening protocol for patients that present with fever and/or a concern for infection. While the specific parameters tested in screening tools differ, they generally consist of tests for a systemic inflammatory response (e.g. SIRS) and/or organ dysfunction (e.g. SOFA) and/or high susceptibility (e.g. immunocompromised) factors.

Trial Locations (1)

20010

Children's National Hospital, Washington D.C.

Sponsors
All Listed Sponsors
collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Rainbow Babies and Children's Hospital

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

George Washington University

OTHER

collaborator

All Children's Research Institute

UNKNOWN

lead

Computer Technology Associates, Inc.

INDUSTRY